Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.
about
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker TeamWhat amyloid ligands can tell us about molecular polymorphism and disease.Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.Imaging Alzheimer's disease pathophysiology with PET.Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic reviewMagnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review
P2860
Q28595520-347E00F5-5066-45BE-93F3-C1A93C440C1DQ36871202-FF1AAB93-BD19-4961-A14E-A92380176E8AQ37590021-81A66ED2-721B-4AA6-A291-3FF9DEC6DCD6Q50044294-C9D02C50-DFAE-4845-B67F-B1CFBB322C51Q51760905-2083A860-2B35-4217-8576-AF7E3EBA681AQ51765788-56D6FC00-9416-4B85-A17B-D5A141A43F78Q55499595-8987F561-A6D0-4A80-945A-7538E7281359Q57174282-8CB29C23-F97A-4F92-8419-57C62779998EQ58722862-7DAC0724-FF88-4FDF-A4A7-7B77F3806819
P2860
Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Use of amyloid PET across the ...... and associated ethical issues.
@en
type
label
Use of amyloid PET across the ...... and associated ethical issues.
@en
prefLabel
Use of amyloid PET across the ...... and associated ethical issues.
@en
P2093
P2860
P1433
P1476
Use of amyloid PET across the ...... and associated ethical issues.
@en
P2093
Antoine Leuzy
Eduardo Rigon Zimmer
Kerstin Heurling
Serge Gauthier
P2860
P304
P356
10.3109/13506129.2014.926267
P577
2014-06-11T00:00:00Z